• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便免疫化学检测结果为阴性者晚期结直肠肿瘤的临床风险分层模型

Clinical risk stratification model for advanced colorectal neoplasia in persons with negative fecal immunochemical test results.

作者信息

Jung Yoon Suk, Park Chan Hyuk, Kim Nam Hee, Park Jung Ho, Park Dong Il, Sohn Chong Il

机构信息

Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.

出版信息

PLoS One. 2018 Jan 11;13(1):e0191125. doi: 10.1371/journal.pone.0191125. eCollection 2018.

DOI:10.1371/journal.pone.0191125
PMID:29324874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5764375/
Abstract

OBJECTIVES

The fecal immunochemical test (FIT) has low sensitivity for detecting advanced colorectal neoplasia (ACRN); thus, a considerable portion of FIT-negative persons may have ACRN. We aimed to develop a risk-scoring model for predicting ACRN in FIT-negative persons.

MATERIALS AND METHODS

We reviewed the records of participants aged ≥40 years who underwent a colonoscopy and FIT during a health check-up. We developed a risk-scoring model for predicting ACRN in FIT-negative persons.

RESULTS

Of 11,873 FIT-negative participants, 255 (2.1%) had ACRN. On the basis of the multivariable logistic regression model, point scores were assigned as follows among FIT-negative persons: age (per year from 40 years old), 1 point; current smoker, 10 points; overweight, 5 points; obese, 7 points; hypertension, 6 points; old cerebrovascular attack (CVA), 15 points. Although the proportion of ACRN in FIT-negative persons increased as risk scores increased (from 0.6% in the group with 0-4 points to 8.1% in the group with 35-39 points), it was significantly lower than that in FIT-positive persons (14.9%). However, there was no statistical difference between the proportion of ACRN in FIT-negative persons with ≥40 points and in FIT-positive persons (10.5% vs. 14.9%, P = 0.321).

CONCLUSIONS

FIT-negative persons may need to undergo screening colonoscopy if they clinically have a high risk of ACRN. The scoring model based on age, smoking habits, overweight or obesity, hypertension, and old CVA may be useful in selecting and prioritizing FIT-negative persons for screening colonoscopy.

摘要

目的

粪便免疫化学检测(FIT)对晚期结直肠肿瘤(ACRN)的检测灵敏度较低;因此,相当一部分FIT检测结果为阴性的人可能患有ACRN。我们旨在开发一种风险评分模型,用于预测FIT检测结果为阴性的人患ACRN的风险。

材料与方法

我们回顾了年龄≥40岁且在健康体检期间接受结肠镜检查和FIT检测的参与者的记录。我们开发了一种风险评分模型,用于预测FIT检测结果为阴性的人患ACRN的风险。

结果

在11873名FIT检测结果为阴性的参与者中,255人(2.1%)患有ACRN。基于多变量逻辑回归模型,在FIT检测结果为阴性的人群中,评分如下:年龄(从40岁起每年),1分;当前吸烟者,10分;超重,5分;肥胖,7分;高血压,6分;既往有脑血管意外(CVA),15分。尽管FIT检测结果为阴性的人中ACRN的比例随着风险评分的增加而增加(从0 - 4分的组中的0.6%增加到35 - 39分的组中的8.1%),但显著低于FIT检测结果为阳性的人(14.9%)。然而,FIT检测结果为阴性且风险评分≥40分的人与FIT检测结果为阳性的人患ACRN的比例之间没有统计学差异(10.5%对14.9%,P = 0.321)。

结论

如果FIT检测结果为阴性的人临床上患ACRN的风险较高,可能需要接受结肠镜筛查。基于年龄、吸烟习惯、超重或肥胖、高血压和既往CVA的评分模型可能有助于选择FIT检测结果为阴性的人并确定其接受结肠镜筛查的优先顺序。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd61/5764375/34535b6baccb/pone.0191125.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd61/5764375/34535b6baccb/pone.0191125.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd61/5764375/34535b6baccb/pone.0191125.g001.jpg

相似文献

1
Clinical risk stratification model for advanced colorectal neoplasia in persons with negative fecal immunochemical test results.粪便免疫化学检测结果为阴性者晚期结直肠肿瘤的临床风险分层模型
PLoS One. 2018 Jan 11;13(1):e0191125. doi: 10.1371/journal.pone.0191125. eCollection 2018.
2
Individualized colorectal cancer screening based on the clinical risk factors: beyond family history of colorectal cancer.基于临床风险因素的个体化结直肠癌筛查:超越结直肠癌家族史。
Gastrointest Endosc. 2018 Jul;88(1):128-135. doi: 10.1016/j.gie.2018.02.041. Epub 2018 Mar 3.
3
Usefulness of risk stratification models for colorectal cancer based on fecal hemoglobin concentration and clinical risk factors.基于粪便血红蛋白浓度和临床危险因素的结直肠癌风险分层模型的实用性。
Gastrointest Endosc. 2019 Jun;89(6):1204-1211.e1. doi: 10.1016/j.gie.2019.02.023. Epub 2019 Feb 25.
4
A Combination of Fecal Immunochemical Test Results and Iron Deficiency Anemia for Detection of Advanced Colorectal Neoplasia in Asymptomatic Men.粪便免疫化学检测结果与缺铁性贫血相结合用于无症状男性晚期结直肠肿瘤的检测
Yonsei Med J. 2017 Sep;58(5):910-917. doi: 10.3349/ymj.2017.58.5.910.
5
The fecal immunochemical test has high accuracy for detecting advanced colorectal neoplasia before age 50.粪便免疫化学检测在50岁之前检测晚期结直肠肿瘤方面具有很高的准确性。
Dig Liver Dis. 2017 May;49(5):557-561. doi: 10.1016/j.dld.2016.12.020. Epub 2016 Dec 24.
6
Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin concentration with risk of advanced colorectal neoplasia.粪便潜血阳性后行结肠镜检查的时间和粪便血红蛋白浓度与结直肠高级别瘤变风险的关系。
Dig Liver Dis. 2019 Apr;51(4):589-594. doi: 10.1016/j.dld.2018.12.008. Epub 2018 Dec 23.
7
Colorectal cancer screening with the fecal immunochemical test in persons aged 30 to 49 years: focusing on the age for commencing screening.30 至 49 岁人群的粪便免疫化学试验用于结直肠癌筛查:重点关注开始筛查的年龄。
Gastrointest Endosc. 2017 Nov;86(5):892-899. doi: 10.1016/j.gie.2017.03.1531. Epub 2017 Apr 3.
8
Yield of repeat colonoscopy in asymptomatic individuals with a positive fecal immunochemical test and recent colonoscopy.在粪便免疫化学试验阳性且近期行结肠镜检查的无症状个体中,重复结肠镜检查的效果。
Gastrointest Endosc. 2019 May;89(5):1037-1043. doi: 10.1016/j.gie.2019.01.012. Epub 2019 Jan 23.
9
Impact of Age on the Risk of Advanced Colorectal Neoplasia in a Young Population: An Analysis Using the Predicted Probability Model.年龄对年轻人群中晚期结直肠肿瘤风险的影响:使用预测概率模型的分析
Dig Dis Sci. 2017 Sep;62(9):2518-2525. doi: 10.1007/s10620-017-4683-y. Epub 2017 Jul 21.
10
Optimization of the surveillance strategy in patients with colorectal adenomas: A combination of clinical parameters and index colonoscopy findings.优化结直肠腺瘤患者的监测策略:临床参数与结肠镜检查结果的联合应用。
J Gastroenterol Hepatol. 2021 Apr;36(4):974-982. doi: 10.1111/jgh.15237. Epub 2020 Sep 10.

引用本文的文献

1
Diagnostic Accuracy Of Fecal Occult Blood Tests For Detecting Proximal Versus Distal Colorectal Neoplasia: A Systematic Review And Meta-Analysis.粪便潜血试验检测近端与远端结直肠肿瘤的诊断准确性:一项系统评价与Meta分析
Clin Epidemiol. 2019 Oct 25;11:943-954. doi: 10.2147/CLEP.S213677. eCollection 2019.

本文引用的文献

1
Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.结直肠癌筛查:美国预防服务工作组的更新证据报告和系统评价。
JAMA. 2016 Jun 21;315(23):2576-94. doi: 10.1001/jama.2016.3332.
2
A Risk Prediction Index for Advanced Colorectal Neoplasia at Screening Colonoscopy.筛查结肠镜检查时晚期结直肠肿瘤的风险预测指数
Am J Gastroenterol. 2015 Jul;110(7):1062-71. doi: 10.1038/ajg.2015.146. Epub 2015 May 26.
3
Diagnostic Accuracy of a Qualitative Fecal Immunochemical Test Varies With Location of Neoplasia But Not Number of Specimens.
定性粪便免疫化学检测的诊断准确性随肿瘤位置而异,但与标本数量无关。
Clin Gastroenterol Hepatol. 2015 Aug;13(8):1472-9. doi: 10.1016/j.cgh.2015.02.021. Epub 2015 Feb 24.
4
BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening.用于识别有2型糖尿病筛查风险的亚裔美国人的体重指数切点。
Diabetes Care. 2015 Jan;38(1):150-8. doi: 10.2337/dc14-2391.
5
Impact of sigmoidoscopy and colonoscopy on colorectal cancer incidence and mortality: an evidence-based review of published prospective and retrospective studies.乙状结肠镜检查和结肠镜检查对结直肠癌发病率和死亡率的影响:基于证据的已发表前瞻性和回顾性研究综述
Intest Res. 2014 Oct;12(4):268-74. doi: 10.5217/ir.2014.12.4.268. Epub 2014 Oct 27.
6
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
7
Endoscopic quality indicators for esophagogastroduodenoscopy in gastric cancer screening.胃癌筛查中食管胃十二指肠镜检查的内镜质量指标
Dig Dis Sci. 2015 Jan;60(1):38-46. doi: 10.1007/s10620-014-3288-y. Epub 2014 Jul 26.
8
Tests and investigations for colorectal cancer screening.结直肠癌筛查的检测与调查
Clin Biochem. 2014 Jul;47(10-11):921-39. doi: 10.1016/j.clinbiochem.2014.04.019. Epub 2014 Apr 24.
9
Development and validation of a risk stratification-based screening model for predicting colorectal advanced neoplasia in Korea.韩国用于预测结直肠高级别瘤变的基于风险分层的筛查模型的开发与验证
J Clin Gastroenterol. 2015 Jan;49(1):41-9. doi: 10.1097/MCG.0000000000000102.
10
Risk of colorectal cancer in patients with acute myocardial infarction and stroke: a nationwide cohort study.急性心肌梗死和中风患者结直肠癌风险:一项全国性队列研究。
Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):1994-9. doi: 10.1158/1055-9965.EPI-13-0444. Epub 2013 Sep 18.